Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.

Wagner, A; Köhm, M; Nordin, A; Svenungsson, E; Pfeilschifter, J M; Radeke, H H

Wagner, A; Köhm, M; Nordin, A; Svenungsson, E; Pfeilschifter, J M; Radeke, H H.

Affiliation

Wagner A; pharmazentrum frankfurt/ZAFES, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Köhm M; Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Nordin A; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine & Pharmacology TMP, Frankfurt am Main, Germany.
Svenungsson E; Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Pfeilschifter JM; Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Radeke HH; pharmazentrum frankfurt/ZAFES, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.

Scand J Immunol ; 82(3): 269-74, 2015 Sep.

Article in En | MEDLINE | ID: mdl-26095613

Subject(s)

Autoimmune Diseases/pathology; Interleukins/blood; Receptors, Somatostatin/metabolism; Scleroderma, Diffuse/pathology; Scleroderma, Limited/pathology; Adult; Aged; Autoimmune Diseases/blood; Biomarkers/blood; Disease Progression; Endothelial Cells/metabolism; Female; Humans; Iloprost/pharmacology; Interleukin-33; Male; Middle Aged; Scleroderma, Diffuse/blood; Scleroderma, Limited/blood; Vasodilator Agents/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Interleukins / Receptors, Somatostatin / Scleroderma, Diffuse / Scleroderma, Limited Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Scand J Immunol Year: 2015 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google